Charalambos (Babis) Andreadis, MD, MSCE
Professor of Clinical Medicine, Department of Medicine, UCSF; Director, Baszucki Lymphoma Therapeutic Initiative, UCSF
Professor of Clinical Medicine, Department of Medicine, UCSF; Director, Baszucki Lymphoma Therapeutic Initiative, UCSF
I am an experienced hematologist in a comprehensive cancer center with clinical and research expertise in hematologic malignancies, cell therapies and stem cell transplantation. I have extensive clinical and research training in these areas and in genetic pharmacoepidemiology, in which I hold a Master’s degree. I have conducted and consulted on numerous clinical research endeavors in patients with hematologic malignancies, and I am currently the Director of the Baszucki Lymphoma Therapeutic Initiative and the hematology clinical research co-chair at UCSF. I have collaborated with colleagues across departments and institutions (BMT-CTN and ALLIANCE) to conduct studies and perform data analysis on several aspects and phases of therapy for these patients. My personal area of interest involves the identification and characterization of genetic determinants of response to and toxicity from cancer therapy.
Oberlin College, Oberlin, OH, BA, 1993, Cum Laude, Biochemistry
College of Physicians & Surgeons, Columbia University, New York, NY, MD, 1998, Medicine
University of Pennsylvania, Philadelphia, PA, MSCE, 2005, Pharmacogenetics/Epidemiology